Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2025-12-26 @ 2:41 PM
NCT ID:
NCT01927406
Eligibility Criteria:
Inclusion Criteria:
* mild or moderate to severe thyroid eye disease in one or both eyes
* age \> 18 years
* informed consent
* intraocular pressure \> 21 mmHg or glaucoma suspect or glaucoma diagnosed in one or both eyes
* not on current prostaglandin analog intraocular pressure lowering therapy
Exclusion Criteria:
* sight threatening thyroid eye disease
* children \< 18 years old
* patients that are not compliant with treatment or follow-up
* patients already on prostaglandin analog treatment
* patients that undergo cosmetic periocular procedures during the study will be excluded from further follow up
* patients that cannot tolerate prostaglandin analog treatment.
* patients with bilateral thyroid eye disease and elevated intraocular pressures that cannot tolerate treatment with timolol or an alternative intraocular pressure lowering medication such as trusopt, combigan, cosopt.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01927406
Study Brief:
Protocol Section:
NCT01927406